Cardiovascular Disease Risk Assessment
Customize your policy alerts
Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB020 alerts
Get alerted when Policy RPLAB020 changes without checking for updates manually.
Monitor payer policy activity
Defines BCBSNM reimbursement policy for laboratory tests used in cardiovascular disease (CVD) risk assessment and screening, including which lipid and biomarker tests are reimbursable or not, and applicable testing intervals for various clinical scenarios.
Changed routine screening interval from every 4 years to every 5 years for a specified population.
Removed allowance for hs-CRP as a general reimbursable test for CVD risk assessment; limited or conditional reimbursement applied.
Measurement of lipoprotein(a) (Lp(a)) once per lifetime (age ≥18) is considered reimbursable.
Added reimbursement code 83876 and later code 0541U and others across updates.
Annual lipid panel screening permitted for individuals at increased risk of dyslipidemia.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.